2023 annual financial data
Pulse Biosciences 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was 367,122.22%.
Operating income was -43,574,000 USD and net income was -42,210,000 USD.
Operating cash flow was -33,041,000 USD.
Get free Pulse Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- -9,000 USD
- Operating income
- -43,574,000 USD
- Net income
- -42,210,000 USD
- Operating cash flow
- -33,041,000 USD